Jgp Global Gestao De Recursos Ltda. Acadia Pharmaceuticals Inc Transaction History

Jgp Global Gestao De Recursos Ltda.

$51.1 Million
Q3 2024

A detailed history of Jgp Global Gestao De Recursos Ltda. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Jgp Global Gestao De Recursos Ltda. holds 34,620 shares of ACAD stock, worth $563,267. This represents 1.04% of its overall portfolio holdings.

Number of Shares

34,620

Previous 36,740 5.77%

Holding current value

$563,267

Previous $597,000 10.89%

% of portfolio

1.04%

Previous 1.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$15.14 - $19.14 $32,096 - $40,576	-2,120 Reduced 5.77%	34,620 $532,000
Q2 2024 Aug 02, 2024	SELL	$14.62 - $18.42 $219 - $276	-15 Reduced 0.04%	36,740 $597,000
Q1 2024 May 08, 2024	BUY	$17.79 - $30.86 $11,474 - $19,904	645 Added 1.79%	36,755 $679,000
Q4 2023 Jan 19, 2024	BUY	$20.78 - $31.77 $410,550 - $627,679	19,757 Added 120.82%	36,110 $1.13 Million
Q3 2023 Nov 01, 2023	SELL	$20.84 - $33.47 $312 - $502	-15 Reduced 0.09%	16,353 $340,000
Q2 2023 Aug 04, 2023	SELL	$17.8 - $25.65 $213 - $307	-12 Reduced 0.07%	16,368 $392,000
Q1 2023 May 05, 2023	SELL	$16.32 - $20.92 $5,858 - $7,510	-359 Reduced 2.14%	16,380 $308,000
Q4 2022 Jan 25, 2023	SELL	$14.2 - $18.63 $56 - $74	-4 Reduced 0.02%	16,739 $266,000
Q3 2022 Nov 04, 2022	BUY	$14.11 - $18.27 $6,518 - $8,440	462 Added 2.84%	16,743 $274,000
Q2 2022 Aug 01, 2022	SELL	$13.01 - $27.22 $117 - $244	-9 Reduced 0.06%	16,281 $229,000
Q1 2022 May 05, 2022	SELL	$20.94 - $27.5 $7,852 - $10,312	-375 Reduced 2.25%	16,290 $395,000
Q4 2021 Feb 03, 2022	SELL	$16.79 - $27.09 $50 - $81	-3 Reduced 0.02%	16,665 $389,000
Q3 2021 Nov 04, 2021	SELL	$15.78 - $24.77 $12,797 - $20,088	-811 Reduced 4.64%	16,668 $277,000
Q2 2021 Aug 09, 2021	BUY	$19.4 - $27.42 $135 - $191	7 Added 0.04%	17,479 $426,000
Q1 2021 May 11, 2021	BUY	$25.02 - $54.99 $437,149 - $960,785	17,472 New	17,472 $451,000
Q4 2020 Jan 27, 2021	SELL	$41.04 - $56.79 $940,472 - $1.3 Million	-22,916 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $2,512 - $3,933	69 Added 0.3%	22,916 $945,000
Q1 2020 May 07, 2020	BUY	$31.65 - $46.87 $27,978 - $41,433	884 Added 4.02%	22,847 $0
Q4 2019 Jan 24, 2020	BUY	$36.21 - $51.4 $6,047 - $8,583	167 Added 0.77%	21,963 $940,000
Q3 2019 Oct 29, 2019	BUY	$22.22 - $44.01 $91,079 - $180,396	4,099 Added 23.16%	21,796 $784,000
Q2 2019 Jul 19, 2019	BUY	$23.32 - $28.12 $198,080 - $238,851	8,494 Added 92.3%	17,697 $473,000
Q1 2019 Apr 24, 2019	BUY	$16.17 - $27.38 $148,812 - $251,978	9,203 New	9,203 $247,000
Q4 2018 Jan 23, 2019	SELL	$14.32 - $22.92 $183,654 - $293,949	-12,825 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$13.03 - $21.81 $167,109 - $279,713	12,825 New	12,825 $266,000
Q2 2018 Aug 10, 2018	SELL	$15.07 - $22.34 $184,954 - $274,178	-12,273 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$26.84 - $39.14 $17,875 - $26,067	666 Added 5.74%	12,273 $370,000
Q3 2017 Nov 09, 2017	BUY	$29.49 - $38.37 $342,290 - $445,360	11,607	11,607 $437,000

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.

Account

Jgp Global Gestao De Recursos Ltda. Acadia Pharmaceuticals Inc Transaction History